NCT04829318: A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
- State
- Completed
- Phase
- Phase 4
- People
- 183 taking part
- Started
- 26 Apr 2021
- Primary completion
- 22 Jul 2024
- Arms
- Esketamine
- Results
- Posted on the registry
- 2 Apr 2021: Trial registered
- 26 Apr 2021: Trial started
- 22 Jul 2024: Trial completed
- 18 Sep 2025: Trial results posted